Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 11, 2023

Evaluating Bradycardia Following Remdesivir Administration in Patients With COVID-19

JAMA Network Open


Additional Info

JAMA Network Open
Identification of Bradycardia Following Remdesivir Administration Through the US Food and Drug Administration American College of Medical Toxicology COVID-19 Toxic Pharmacovigilance Project
JAMA Netw Open 2023 Feb 14;6(2)e2255815, JM Devgun, R Zhang, J Brent, P Wax, K Burkhart, A Meyn, S Campleman, S Abston, K Aldy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading